Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'

Summary

Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.

Lotu Radar provides attributed news summaries and links to the original publisher. Full reporting and copyright remain with the source.